BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22374993)

  • 21. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
    Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in integrin genes and lymphoma risk.
    Shen M; Zheng T; Lan Q; Zhang Y; Hosgood HD; Zahm SH; Holford TR; Leaderer B; Yeager M; Yuenger J; Chanock S; Rothman N
    Leuk Res; 2011 Jul; 35(7):968-70. PubMed ID: 21239057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.
    Zhang Y; Wang R; Holford TR; Leaderer B; Zahm SH; Boyle P; Zhu Y; Qin Q; Zheng T
    Cancer Causes Control; 2007 May; 18(4):351-9. PubMed ID: 17206533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
    Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
    Gustafson HL; Yao S; Goldman BH; Lee K; Spier CM; LeBlanc ML; Rimsza LM; Cerhan JR; Habermann TM; Link BK; Maurer MJ; Slager SL; Persky DO; Miller TP; Fisher RI; Ambrosone CB; Briehl MM
    Am J Hematol; 2014 Jun; 89(6):639-45. PubMed ID: 24633940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma.
    Li Y; Zheng T; Kilfoy BA; Lan Q; Holford T; Han X; Zhao P; Dai M; Leaderer B; Rothman N; Zhang Y
    Am J Hematol; 2010 Mar; 85(3):213-5. PubMed ID: 20131310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma.
    Bi X; Zheng T; Lan Q; Xu Z; Chen Y; Zhu G; Foss F; Kim C; Dai M; Zhao P; Holford T; Leaderer B; Boyle P; Deng Q; Chanock SJ; Rothman N; Zhang Y
    Am J Hematol; 2012 Aug; 87(8):766-9. PubMed ID: 22649007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.
    Jiao J; Zheng T; Lan Q; Chen Y; Deng Q; Bi X; Kim C; Holford T; Leaderer B; Boyle P; Ba Y; Xia Z; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2012 Nov; 21(6):580-4. PubMed ID: 22430443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index and risk of malignant lymphoma in Scandinavian men and women.
    Chang ET; Hjalgrim H; Smedby KE; Akerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
    J Natl Cancer Inst; 2005 Feb; 97(3):210-8. PubMed ID: 15687364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer.
    McCullough LE; Eng SM; Bradshaw PT; Cleveland RJ; Steck SE; Terry MB; Shen J; Crew KD; Rossner P; Ahn J; Ambrosone CB; Teitelbaum SL; Neugut AI; Santella RM; Gammon MD
    Ann Epidemiol; 2015 Apr; 25(4):263-9. PubMed ID: 25703993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
    Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
    Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma.
    Ng CH; Janoo-Gilani R; Sipahimalani P; Gallagher RP; Gascoyne RD; Connors JM; Weber JP; Lai AS; Leach S; Le ND; Brooks-Wilson AR; Spinelli JJ
    Cancer Causes Control; 2010 Jan; 21(1):11-22. PubMed ID: 19821039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies.
    Larsson SC; Wolk A
    Eur J Cancer; 2011 Nov; 47(16):2422-30. PubMed ID: 21733676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
    Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
    Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-G Gene Polymorphism in Egyptian Patients with Non-Hodgkin Lymphoma and its Clinical Outcome.
    Tawfeek GA; Alhassanin S
    Immunol Invest; 2018 Apr; 47(3):315-325. PubMed ID: 29388862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
    Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.